intracranial arteriosclerosis
intracranial arteriosclerosis
Explore linked clinical trials. Standard reference: MONDO:000163280 results · Page 1 of 4
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease, Phase IIb | Arterial Occlusive Diseases, Intracranial Atherosclerosis, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-10-08 | NCT07864649 | |
| Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis | Arterial Occlusive Diseases, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-10-08 | NCT05047172 | |
| The Erlanger Stroke Registry (ESPro) is the Only Ongoing Prospective Population-based Stroke Registry in Germany, Started in 1994. ESPro Includes All Hospitalized and Non-hospitalized Patients With Stroke in the Community of Erlangen (120.000 Inhabitants), With a Long-life Follow-up. | Arterial Occlusive Diseases, Embolism and Thrombosis, Hemorrhage, Infarction, Intracranial Embolism and Thrombosis, Intracranial Hemorrhages, Leukoencephalopathies, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, arteriosclerosis disorder, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral infarction, cerebrovascular disorder, cognitive disorder, dementia, intracerebral hemorrhage, intracranial arterial disease, intracranial arteriosclerosis, intracranial thrombosis, ischemic disease, multi-infarct dementia, nervous system disorder, psychiatric disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-10-02 | NCT07771335 | |
| Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, stroke disorder, tauopathy, vascular dementia, vascular disorder | Active, not recruiting | Not applicable | 2026-10-02 | NCT04337255 | |
| Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers | Alzheimer disease, Arterial Occlusive Diseases, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Creutzfeldt Jacob disease, Disease Attributes, Dyskinesias, Frontotemporal Lobar Degeneration, Huntington disease, Infections, Leukoencephalopathies, Lewy body dementia, Mixed Dementias, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, cerebrovascular disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, prion disease, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Active, not recruiting | Not applicable | 2026-09-21 | NCT05596760 | |
| Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment | Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Leukoencephalopathies, Mild Cognitive Impairment, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, psychiatric disorder, vascular dementia, vascular disorder | Active, not recruiting | Not applicable | 2026-09-18 | NCT07149038 | |
| Pulsed Electromagnetic Field Treatment With Dementia Patients | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, Lewy body dementia, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-09-17 | NCT06862557 | |
| RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling | Arterial Occlusive Diseases, arteriosclerosis disorder, brain disorder, cardiovascular disorder, carotid artery disorder, carotid stenosis, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-09-15 | NCT07819643 | |
| Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial | Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, psychiatric disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-09-15 | NCT07605130 | |
| The BRAIN App (Phase 2 SBIR) | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-09-15 | NCT06298474 | |
| Making Connections Thru Music | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-09-15 | NCT06079216 | |
| Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY | Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Hemorrhage, Intracranial Hemorrhages, Leukoencephalopathies, Mild Cognitive Impairment, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracerebral hemorrhage, intracranial arterial disease, intracranial arteriosclerosis, ischemic stroke, nervous system disorder, psychiatric disorder, stroke disorder, subarachnoid hemorrhage, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-09-14 | NCT04916210 | |
| High-resolution Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaques in Ischemic Stroke | Arterial Occlusive Diseases, Intracranial Atherosclerosis, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2026-09-11 | NCT05897645 | |
| Florida Cerebrovascular Disease Biorepository and Genomics Center | Arterial Occlusive Diseases, Cardiovascular Abnormalities, Cerebral Small Vessel Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Embolism and Thrombosis, Fistula, Hemorrhage, Hypoxia, Hypoxia, Brain, Infarction, Intracranial Embolism and Thrombosis, Intracranial Hemorrhages, Leukoaraiosis, Leukoencephalopathies, Moyamoya disease, Necrosis, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, Subarachnoid Hemorrhage, Aneurysmal, Thromboembolism, Vascular Fistula, arteriosclerosis disorder, arteriovenous hemangioma/malformation, brain disorder, brain hypoxia - ischemia, brain infarction, brain ischemia, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, congenital arteriovenous fistula, dementia, fibromuscular dysplasia, hereditary disease, intracerebral hemorrhage, intracranial arterial disease, intracranial arteriosclerosis, intracranial thrombosis, ischemic disease, ischemic stroke, nervous system disorder, psychiatric disorder, reversible cerebral vasoconstriction syndrome, stroke disorder, subarachnoid hemorrhage, transient ischemic attack, vascular dementia, vascular disorder, vascular malformation | Active, not recruiting | Not stated | 2026-09-03 | NCT05491980 | |
| Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI) | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Frontotemporal Lobar Degeneration, Leukoencephalopathies, Lewy body dementia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, disease, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Not yet recruiting | Not stated | 2026-09-02 | NCT07200739 | |
| Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS) | Arterial Occlusive Diseases, Intracranial Atherosclerosis, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-09-01 | NCT07468448 | |
| ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing | Alzheimer disease, Apnea, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Dyssomnias, Leukoencephalopathies, Lewy body dementia, Mild Cognitive Impairment, Mixed Dementias, Respiration Disorders, Sleep Disorders, Intrinsic, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, movement disorder, nervous system disorder, neurodegenerative disease, obstructive sleep apnea syndrome, parkinsonian disorder, psychiatric disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-08-20 | NCT04335994 | |
| Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Frontotemporal Lobar Degeneration, Huntington disease, Leukoencephalopathies, Lewy body dementia, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, arteriosclerosis disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, choreatic disease, cognitive disorder, corticobasal degeneration disorder, cranial nerve neuropathy, dementia, eye disorder, frontotemporal dementia, hereditary disease, inherited neurodegenerative disorder, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, motor neuron disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, parkinsonian disorder, primary dysautonomia, progressive supranuclear palsy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Active, not recruiting | Not stated | 2026-08-10 | NCT06209515 | |
| Plaque Characteristics Predict Recurrent Stroke in MCA Stroke Patients | Arterial Occlusive Diseases, Intracranial Atherosclerosis, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2026-08-06 | NCT06404242 | |
| Colchicine Use in Intracranial Atherosclerotic Disease | Arterial Occlusive Diseases, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, vascular disorder | Recruiting | Phase 2 | 2026-07-30 | NCT05503225 | |
| Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-07-23 | NCT07721701 | |
| PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke | Arterial Occlusive Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Atherosclerotic, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-07-15 | NCT07466251 | |
| Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial | Arterial Occlusive Diseases, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-07-15 | NCT04948749 | |
| Imaging of Brain Amyloid Plaques in the Aging Population | Alzheimer disease, Arterial Occlusive Diseases, Frontotemporal Lobar Degeneration, Leukoencephalopathies, Lewy body dementia, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Enrolling by invitation | Phase 4 | 2026-06-23 | NCT00950430 | |
| PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis | Arterial Occlusive Diseases, Intracranial Atherosclerosis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Atherosclerotic, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, vascular disorder | Recruiting | Phase 4 | 2026-06-12 | NCT06902740 |